a recent report by sommar et al. 1 published in the Journal of Plastic, Reconstructive & Aesthetic Surgery provides evidence that dermally derived human fibroblastic cells, cultured as three-dimensional constructs on macroporous gelatin microcarriers encapsulated in platelet-rich plasma, are able to undergo induced osteogenic and chondrogenic differentiation in vitro. the authors suggest that human dermal fibroblasts represent a convenient cell source for the engineering of bone and cartilage tissue. the reported findings are, therefore, relevant to the general field of cell-based regenerative medicine.
tissue engineering and regenerative technologies are of particular importance in musculoskeletal medicine, in view of the prevalence and burden of degenerative diseases that involve the articular joints and intervertebral discs, age-related diseases such as osteoporosis, and physical-trauma-related pathologies, such as fractures and tears, which affect bone, cartilage, and other soft tissues, including ligaments and tendons. Conventional reconstructive approaches developed in the last several decades have been highly effective in restoring physical function and improving the lives of patients, but these methods have inherent limitations. For example, artificial joints constructed from bio materials, including titanium or chrome-cobalt alloys and ultra-high-molecular-weight polyethylene, result in stress shielding and the production of wear debris particulates that eventually compromise bone quality, ultimately leading to failure and the need for revision surgery. 2 thus, although biomaterials are able to simulate some tissue characteristics, the quality and success of repair is ultimately dependent on the biological activities of the tissue and the constituent cell types. accordingly, reparative approaches based increasingly on biological and cellular principles are being actively sought, with the emergence of a new scientific discipline-tissue engineering.
tissue engineering is the application of principles of life science and engineering to create tissue substitutes capable of re storing function to diseased or injured tissues. this approach requires three basic components: cells, scaffolds, and biological signals ( Figure 1) . 3 with respect to cells, major technical challenges include sourcing, adequacy of quantity and quality, and phenotypic stability and requirements. in addition, for a number of safety and ethical reasons, autologous cells are generally preferred over is thus directly relevant to the issue of cell sourcing in tissue engineering. the main finding of the study by sommar et al. 1 is that human dermal fibroblasts, isolated by way of a relatively simple procedure, have the ability to differentiate in vitro into osteoblasts and chondrocytes, the constituent cell types of bone and cartilage, respectively. using autologous cells in skele tal tissue engineering is, therefore, highly feasible. it should be noted, however, that the findings of the osteogenic and chondro genic potential of dermal fibroblasts are not novel, as a number of previous reports exist on osteogenic and chondrogenic differen tiation of these cells. 4, 5 in addition, differen tiation was induced using traditional osteogenesis and chondrogenesis culture medium supple ments and conditions, 6 and was charac terized primarily on the basis of histological and immunohistochemical parameters. thus, the results provide no new mechanistic information on the biological pathways or signals responsible for the initiation and regulation of osteogenic and chondrogenic differentiation of dermal fibroblasts.
another noteworthy aspect of this study is the application of a commercial biomaterial scaffold (Cultispher-Gl®, Percell Biolytica aB, sweden), a macroporous, gelatin-based microcarrier, to produce three-dimensional constructs using dermal fibroblasts. a number of hydrogels, including algi nate, agarose, collagen, and polyethylene glycol, have been used to produce three-dimensional stem-cell-based constructs that support guided differentiation. 7 Because no direct comparison was made in this study between Cultispher-Gl® and other, more commonly used hydrogels, there is no specific evidence to support the advantage of using this particular biomaterial for cell-based tissue engineering, particularly regarding long-term biocompatibility and tissue reactions in vivo, including inflammatory and immune reactions. mechanical characteristics, which were not measured in this study, represent another key requirement for engineering functional skeletal tissue. it is noteworthy that, even after extensive in duction of chondrogenic differentiation, three-dimensional cartilaginous constructs derived from adult bone marrow mesenchymal stem cells exhibit mechanical properties inferior to those of chondrocyte-derived constructs. 8 the underlying reason for this difference is not known, and how dermal fibroblasts compare to other adult stem cells in this regard remains to be seen.
Cell-based tissue engineering is one of the most promising approaches in regenerative medicine. adult stem cells are a particularly attractive cell source as they can be obtained from autologous sources, thereby minimizing safety and ethical complications. 9 For adult dermal fibroblasts to be con sidered a viable source of adult stem cells, a direct com parison with bonemarrow-derived mesenchymal stem cells-the de facto gold standardmust be carried out. in addition, efficient and repro ducible cell isolation and expansion procedures must be developed, and characterization parameters must be established that predict the differentiation capabilities of each batch of cell isolates and the phenotypic stability of the differentiated cells. For biomaterial scaffolds to be directly applicable to three-dimensional tissue construction, desirable properties include ease of cell seeding, optimal bio degradability, support of cell expansion and guided differen tiation, and biocompatibility. a critical requirement of a functional skeletal tissue-engineered construct is that it must exhibit mechanical properties appropriate for and compatible with subsequent tissue function, such as load bearing and joint articulation. another challenge in regenera tive technologies is multiphasic tissue engineering, as most tissues and organs are made up of multiple differentiated cell types distributed in a structurally and spatially defined manner. a number of approaches have been explored to accomplish this goal, such as three-dimensional bio material printing for osteo chondral tissue engineering. 10 Finally, a major issue that must be taken into consideration in functional tissue engineering is the inherent differentiation fate and stability of the starting cell types; in other words, a judicious choice of the starting cell type(s), seeded into a three-dimensional scaffold in a spatially guided manner, may in fact be exploited to facilitate the engineering of optimum multiphasic tissue. in this regard, it is critical to ascertain the differentiation characteristics of adult stem cells derived from various sources, including bone marrow, adipose tissue, bone, ligament, as well as dermal fibro blasts. with this information, specific cell type(s), with well characterized and predict able differentiation phenotypes, may be placed into three-dimensionally specific sites in an appropriate bio material scaffold to enhance the en gineering of multiphasic tissue constructs.
